Literature DB >> 7514975

Pharmacological treatment of gallstones. Practical guidelines.

A Lanzini1, T C Northfield.   

Abstract

Laparoscopic cholecystectomy is the treatment of choice for symptomatic cholelithiasis. Medical treatment is indicated for patients who are not fit or are afraid of surgery. For any form of medical treatment to be effective gallstones must be cholesterol rich, thus radiolucent, and the cystic duct must be patent, as indicated by gallbladder opacification on oral cholecystography. Three forms of medical treatment are currently available for clinical use--oral bile acids, bile acids as adjuncts to lithotripsy and contact dissolution using methyltertbutylether. The choice of treatment depends mainly on gallstone size. Gallstones < 6 mm in diameter are best treated with oral bile acids, chenodeoxycholic acid 15 mg/kg/day or ursodeoxycholic acid 10 mg/kg/day given alone or in combination (5 mg/kg/day each). Careful patient selection and bedtime administration of the whole daily bile acid dose enhance treatment, and may achieve up to 75% complete dissolution annually. Single stones < 30 mm in diameter or multiple stones (n < 3) are best treated with lithotripsy combined with oral bile acid for dissolution of fragments. Annual dissolution rates are about 80 and 40% for single and multiple stones, respectively. Stones of any size and number can be dissolved by direct contact dissolution using methyltertbutylether. Dissolution has been reported to be complete in almost 100% of stones, but debris is frequently left behind in the gallbladder. Following dissolution using any form of treatment, gallstones recur in about 50% of patients, and cannot be reliably prevented by low dose bile acid or dietary manipulations. Failing prevention, early detection and retreatment of recurrent stones is the best alternative option as a long term strategy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514975     DOI: 10.2165/00003495-199447030-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  55 in total

1.  Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial.

Authors:  S Bellentani; G Tabarroni; T Barchi; I Ferretti; N Fratti; E Villa; F Manenti
Journal:  J Hepatol       Date:  1989-01       Impact factor: 25.083

2.  Shock-wave lithotripsy of gallbladder stones. The first 175 patients.

Authors:  M Sackmann; M Delius; T Sauerbruch; J Holl; W Weber; E Ippisch; U Hagelauer; O Wess; W Hepp; W Brendel
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

3.  Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.

Authors:  M J Coyne; G G Bonorris; L I Goldstein; L J Schoenfield
Journal:  J Lab Clin Med       Date:  1976-02

4.  In vitro dissolution of cholesterol gallstones. A study of factors influencing rate and a comparison of solvents.

Authors:  M J Allen; T J Borody; J L Thistle
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

5.  Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

Authors:  R Poupon; Y Chrétien; R E Poupon; F Ballet; Y Calmus; F Darnis
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

6.  Dissolution of cholesterol gall stones using methyltertbutyl ether: a safe effective treatment.

Authors:  J McNulty; A Chua; J Keating; S Ah-Kion; D G Weir; P W Keeling
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 7.  Gallbladder stones: shockwave therapy.

Authors:  M Sackmann
Journal:  Baillieres Clin Gastroenterol       Date:  1992-11

8.  Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action.

Authors:  P N Maton; G M Murphy; R H Dowling
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

9.  Mathematical model of biliary lipid secretion: a quantitative analysis of physiological and biochemical data from man and other species.

Authors:  N A Mazer; M C Carey
Journal:  J Lipid Res       Date:  1984-09       Impact factor: 5.922

10.  Incidence of gallstones in a Danish population.

Authors:  K H Jensen; T Jørgensen
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  3 in total

1.  Successful topical dissolution of cholesterol gallbladder stones using ethyl propionate.

Authors:  A F Hofmann; A Amelsberg; O Esch; C D Schteingart; K Lyche; H Jinich; E Vansonnenberg; H B D'Agostino
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Laparoscopic cholecystectomy in adult cystic fibrosis.

Authors:  D S McGrath; C Short; C P Bredin; W O Kirwan; E Rooney; R Meeke
Journal:  Ir J Med Sci       Date:  1997 Apr-Jun       Impact factor: 1.568

Review 3.  The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.

Authors:  Sanjay K Nigam; Kevin T Bush; Vibha Bhatnagar; Samuel M Poloyac; Jeremiah D Momper
Journal:  Clin Pharmacol Ther       Date:  2020-04-11       Impact factor: 6.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.